Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1941220
PUBLISHER: IMARC | PRODUCT CODE: 1941220
Reproductive Genetics Market Report by Product Type, Procedure Type, Technology, Application, and Region 2026-2034
PUBLISHED:
PAGES: 139 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global reproductive genetics market size reached USD 9.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 62.2 Billion by 2034, exhibiting a growth rate (CAGR) of 23.87% during 2026-2034. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the reproductive genetics market share.
Reproductive Genetics Market Analysis:
- Major Market Drivers: The market for reproductive genetics is driven by increasing awareness of inherited disorders, increasing use of sophisticated genetic testing, and heightened demand for customized fertility therapies. Advanced gene sequencing and diagnostic technologies, along with changing reproductive healthcare infrastructure, are pushing adoption and enhancing access to early diagnosis and intervention solutions.
- Key Market Trends: Some of the emerging trends are non-invasive prenatal testing, preimplantation genetic testing, and implementation of artificial intelligence in diagnostics. Personalized reproductive healthcare, growth in genetic counseling services, and emphasis on predictive analytics are transforming the market. Growing partnerships among research centers and clinics further drive innovation and patient-centric reproductive solutions.
- Competitive Landscape: The market is marked by competition based on innovation, with companies banking on technology improvement, quality of services, and strategic partnerships. Firms invest their efforts in increasing diagnostic services, precision, and patient experience. Research institutions and health providers are the usual partners in efforts to increase market presence and reach new patient bases.
- Challenges and Opportunities: Challenges are presented in the form of ethical issues, regulatory hurdles, and the expense of sophisticated genetic testing. Low awareness in some areas also holds back adoption. Oppositely, opportunities present themselves in creating cost-effective testing options, increasing genetic counseling, and applying AI and machine learning to enhance accuracy, accessibility, and personalized reproductive healthcare outcomes.
Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.
Reproductive Genetics Market Trends:
The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.
Key Market Segmentation:
Product Type Insights:
- Kits
- Laboratory Developed Tests (LDT)
- Reagents and Consumables
Procedure Type Insights:
- Carrier Screening
- Pre-Natal Screening
- Pre-Implantation Genetic Testing
- Infertility Genetic Testing
Technology Insights:
- Next-Generation Sequencing
- Polymerase Chain Reaction
- In Situ Hybridization (ISH/FISH)
- Microarray
Application Insights:
- Aneuploidy
- Structural Chromosomal Abnormality
- Single Gene Disorder
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
- The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for reproductive genetics. Some of the factors driving the North America reproductive genetics market included its continual technological advancements in the field of genetics, the rising adoption of preventive healthcare high healthcare expenditure, etc.
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1.How big is the reproductive genetics market?
- 2.What is the future outlook of reproductive genetics market?
- 3.What are the key factors driving the reproductive genetics market?
Product Code: SR112026A10134
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Reproductive Genetics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Laboratory Developed Tests (LDT)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Reagents and Consumables
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Procedure Type
- 7.1 Carrier Screening
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Pre-Natal Screening
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Pre-Implantation Genetic Testing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Infertility Genetic Testing
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Technology
- 8.1 Next-Generation Sequencing
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Polymerase Chain Reaction
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 In Situ Hybridization (ISH/FISH)
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Microarray
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Application
- 9.1 Aneuploidy
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Structural Chromosomal Abnormality
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Single Gene Disorder
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
- 11.1 Overview
- 11.2 Drivers
- 11.3 Restraints
- 11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Bangkok Genomics Innovation Public Company Limited
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Centogene N.V.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Fulgent Genetics Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Igenomix (Vitrolife Group)
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Invitae Corporation
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Laboratory Corporation of America Holdings
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 PerkinElmer Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Thermo Fisher Scientific Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.1 Bangkok Genomics Innovation Public Company Limited
Product Code: SR112026A10134
List of Figures
- Figure 1: Global: Reproductive Genetics Market: Major Drivers and Challenges
- Figure 2: Global: Reproductive Genetics Market: Sales Value (in Billion USD), 2020-2025
- Figure 3: Global: Reproductive Genetics Market Forecast: Sales Value (in Billion USD), 2026-2034
- Figure 4: Global: Reproductive Genetics Market: Breakup by Product Type (in %), 2025
- Figure 5: Global: Reproductive Genetics Market: Breakup by Procedure Type (in %), 2025
- Figure 6: Global: Reproductive Genetics Market: Breakup by Technology (in %), 2025
- Figure 7: Global: Reproductive Genetics Market: Breakup by Application (in %), 2025
- Figure 8: Global: Reproductive Genetics Market: Breakup by Region (in %), 2025
- Figure 9: Global: Reproductive Genetics (Kits) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 10: Global: Reproductive Genetics (Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 11: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 12: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 13: Global: Reproductive Genetics (Reagents and Consumables) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 14: Global: Reproductive Genetics (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 15: Global: Reproductive Genetics (Carrier Screening) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 16: Global: Reproductive Genetics (Carrier Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 17: Global: Reproductive Genetics (Pre-Natal Screening) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 18: Global: Reproductive Genetics (Pre-Natal Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 19: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 20: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 21: Global: Reproductive Genetics (Infertility Genetic Testing) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 22: Global: Reproductive Genetics (Infertility Genetic Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 23: Global: Reproductive Genetics (Next-Generation Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 24: Global: Reproductive Genetics (Next-Generation Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 25: Global: Reproductive Genetics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 26: Global: Reproductive Genetics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 27: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 28: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 29: Global: Reproductive Genetics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 30: Global: Reproductive Genetics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 31: Global: Reproductive Genetics (Aneuploidy) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 32: Global: Reproductive Genetics (Aneuploidy) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 33: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 34: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 35: Global: Reproductive Genetics (Single Gene Disorder) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 36: Global: Reproductive Genetics (Single Gene Disorder) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 37: Global: Reproductive Genetics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 38: Global: Reproductive Genetics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 39: North America: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 40: North America: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 41: United States: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 42: United States: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 43: Canada: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 44: Canada: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 45: Asia-Pacific: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 46: Asia-Pacific: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 47: China: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 48: China: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 49: Japan: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 50: Japan: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 51: India: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 52: India: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 53: South Korea: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 54: South Korea: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 55: Australia: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 56: Australia: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 57: Indonesia: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 58: Indonesia: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 59: Others: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 60: Others: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 61: Europe: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 62: Europe: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 63: Germany: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 64: Germany: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 65: France: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 66: France: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 67: United Kingdom: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 68: United Kingdom: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 69: Italy: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 70: Italy: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 71: Spain: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 72: Spain: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 73: Russia: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 74: Russia: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 75: Others: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 76: Others: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 77: Latin America: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 78: Latin America: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 79: Brazil: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 80: Brazil: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 81: Mexico: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 82: Mexico: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 83: Others: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 84: Others: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 85: Middle East and Africa: Reproductive Genetics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 86: Middle East and Africa: Reproductive Genetics Market: Breakup by Country (in %), 2025
- Figure 87: Middle East and Africa: Reproductive Genetics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 88: Global: Reproductive Genetics Industry: Drivers, Restraints, and Opportunities
- Figure 89: Global: Reproductive Genetics Industry: Value Chain Analysis
- Figure 90: Global: Reproductive Genetics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Reproductive Genetics Market: Key Industry Highlights, 2025 and 2034
- Table 2: Global: Reproductive Genetics Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
- Table 3: Global: Reproductive Genetics Market Forecast: Breakup by Procedure Type (in Million USD), 2026-2034
- Table 4: Global: Reproductive Genetics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
- Table 5: Global: Reproductive Genetics Market Forecast: Breakup by Application (in Million USD), 2026-2034
- Table 6: Global: Reproductive Genetics Market Forecast: Breakup by Region (in Million USD), 2026-2034
- Table 7: Global: Reproductive Genetics Market: Competitive Structure
- Table 8: Global: Reproductive Genetics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.